Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › IncellDx Inks Chinese Collaboration, Distribution Agreements

IncellDx Inks Chinese Collaboration, Distribution Agreements

Aug 05, 2019
|
staff reporter

NEW YORK – IncellDx and Kindstar Global announced today that they have signed master collaboration and exclusive distribution agreements for three of IncellDx's single-cell immuno-oncology and oncology diagnostic products for China. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14
Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June

  2. FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

  3. FDA Issues Warning Letter to Luminex

  4. Foundation Medicine Shifts Focus to Early Cancer Detection With Lexent Bio Acquisition

    Premium

  5. T2 Biosystems Preliminary Q2 Revenues Up About 40 Percent; Firm Launches COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.